Earnings call: Insulet Corporation boasts robust Q1 growth, plans expansion By Investing.com

Insulet (NASDAQ: [PODD](/equities/insulet-corp)) Corporation (NASDAQ: PODD), a leader in tubeless insulin pump technology, has reported a strong first quarter in 2024, with a 21% increase in total Omnipod revenue, driven by the Omnipod 5 au
Read more...